CN108191745A - The preparation method of 2- methylol -3,4- dimethoxy-pyridines - Google Patents
The preparation method of 2- methylol -3,4- dimethoxy-pyridines Download PDFInfo
- Publication number
- CN108191745A CN108191745A CN201810014813.4A CN201810014813A CN108191745A CN 108191745 A CN108191745 A CN 108191745A CN 201810014813 A CN201810014813 A CN 201810014813A CN 108191745 A CN108191745 A CN 108191745A
- Authority
- CN
- China
- Prior art keywords
- dimethoxy
- acetic anhydride
- dimethoxypyridine
- dichloromethane
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- BKTHTLOKUUJKDF-UHFFFAOYSA-N (3,4-dimethoxypyridin-2-yl)methanol Chemical class COC1=CC=NC(CO)=C1OC BKTHTLOKUUJKDF-UHFFFAOYSA-N 0.000 title abstract description 34
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 135
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 84
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 45
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 238000003756 stirring Methods 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 15
- 239000003513 alkali Substances 0.000 claims abstract description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 11
- 230000007062 hydrolysis Effects 0.000 claims abstract description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 49
- VPGBIRMKRPLRKJ-UHFFFAOYSA-N 3,4-dimethoxy-2-methylpyridine Chemical compound COC1=CC=NC(C)=C1OC VPGBIRMKRPLRKJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 150000004075 acetic anhydrides Chemical class 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 238000004064 recycling Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- UMVFRRJTPKYVAY-UHFFFAOYSA-N 3,4-dimethoxy-2-methyl-1-oxidopyridin-1-ium Chemical compound COC1=CC=[N+]([O-])C(C)=C1OC UMVFRRJTPKYVAY-UHFFFAOYSA-N 0.000 abstract description 21
- 238000010907 mechanical stirring Methods 0.000 abstract description 6
- YYRIKJFWBIEEDH-UHFFFAOYSA-N 2-(chloromethyl)-3,4-dimethoxypyridine;hydrochloride Chemical compound [Cl-].COC1=CC=[NH+]C(CCl)=C1OC YYRIKJFWBIEEDH-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 6
- 238000005917 acylation reaction Methods 0.000 description 6
- -1 3,4-dimethoxy-2-methylpyridine acetate Chemical compound 0.000 description 5
- 230000010933 acylation Effects 0.000 description 5
- 238000005660 chlorination reaction Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000007031 hydroxymethylation reaction Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 3
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229960005019 pantoprazole Drugs 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NGGPLHHTRNJSDT-UHFFFAOYSA-N 3-methoxy-2-methylpyran-4-one Chemical compound COC1=C(C)OC=CC1=O NGGPLHHTRNJSDT-UHFFFAOYSA-N 0.000 description 2
- TWXMQDRFBLSXFN-UHFFFAOYSA-N 4-chloro-3-methoxy-2-methyl-1-oxidopyridin-1-ium Chemical compound COC1=C(C)[N+]([O-])=CC=C1Cl TWXMQDRFBLSXFN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940043353 maltol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- ZWFCXDBCXGDDOM-UHFFFAOYSA-N 2-(chloromethyl)-3,4-dimethoxypyridine Chemical compound COC1=CC=NC(CCl)=C1OC ZWFCXDBCXGDDOM-UHFFFAOYSA-N 0.000 description 1
- OXXDGKNPRNPMLS-UHFFFAOYSA-N 2-Hydroxy-3-methyl-4H-pyran-4-one Natural products CC1=C(O)OC=CC1=O OXXDGKNPRNPMLS-UHFFFAOYSA-N 0.000 description 1
- GNWSQENQZGWCSW-UHFFFAOYSA-N 3-methoxy-2-methyl-1h-pyridin-4-one Chemical compound COC1=C(C)N=CC=C1O GNWSQENQZGWCSW-UHFFFAOYSA-N 0.000 description 1
- SWMLTVAXDGUWMC-UHFFFAOYSA-N 3-methylpyridin-1-ium;acetate Chemical compound CC([O-])=O.CC1=CC=C[NH+]=C1 SWMLTVAXDGUWMC-UHFFFAOYSA-N 0.000 description 1
- RYGXNMUVOHCPBF-UHFFFAOYSA-N 4-chloro-3-methoxy-2-methylpyridine Chemical compound COC1=C(C)N=CC=C1Cl RYGXNMUVOHCPBF-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000006198 methoxylation reaction Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- CFZKDDTWZYUZKS-UHFFFAOYSA-N picoline N-oxide Chemical compound CC1=CC=CC=[N+]1[O-] CFZKDDTWZYUZKS-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明公开了一种2‑羟甲基‑3,4‑二甲氧基吡啶的制备方法,将20~30kg 3,4‑二甲氧基‑2‑甲基吡啶‑N‑氧化物加入到10~20kg的乙酸中,机械搅拌下加热,完全溶解;称取50~75kg的乙酸酐,在搅拌下缓慢加入上述体系中;然后在85~95℃下保温15~16h;减压蒸馏出80~90%乙酸酐后,降至18~25℃,缓慢加碱调pH至12~13,升温搅拌水解;向体系中加二氯甲烷0.8~1.2kg,搅拌1h,静置分液,再用等量二氯甲烷分别萃取2次,向合并的萃取液中加无水硫酸钠,搅拌干燥,旋蒸,回收二氯甲烷,即得。本发明收率高,反应条件温和,安全可靠,降低乙酸酐用量,降低成本。
The invention discloses a preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine, adding 20-30 kg of 3,4-dimethoxy-2-picoline-N-oxide into In 10-20kg of acetic acid, heat it under mechanical stirring to dissolve completely; weigh 50-75kg of acetic anhydride, slowly add it into the above system under stirring; then keep it warm at 85-95°C for 15-16h; After ~90% acetic anhydride, lower it to 18~25°C, slowly add alkali to adjust the pH to 12~13, heat up and stir for hydrolysis; add 0.8~1.2kg of dichloromethane to the system, stir for 1h, let stand to separate the liquid, and then use Equal amounts of dichloromethane were extracted twice respectively, anhydrous sodium sulfate was added to the combined extracts, stirred and dried, rotary evaporated, and dichloromethane recovered to obtain the product. The invention has high yield, mild reaction conditions, safety and reliability, reduces the consumption of acetic anhydride and reduces the cost.
Description
技术领域technical field
本发明属于医药中间体合成技术领域,涉及一种2-羟甲基-3,4-二甲氧基吡啶的制备方法。The invention belongs to the technical field of synthesis of pharmaceutical intermediates, and relates to a preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine.
背景技术Background technique
潘多拉唑是一种质子泵抑制剂类药物,近年在国际广泛用于胃肠道疾病,主要治疗胃溃疡、十二指肠和反流性食管炎,由德国Byk Gulden公司研发;2-氯甲基-3,4-二甲氧基吡啶盐酸盐是合成潘多拉唑两个中间体之一,2-羟甲基-3,4-二甲氧基吡啶是合成2-氯甲基-3,4-二甲氧基吡啶盐酸盐的重要中间体。Pandoprazole is a proton pump inhibitor drug, which has been widely used in gastrointestinal diseases in the world in recent years, mainly for the treatment of gastric ulcer, duodenum and reflux esophagitis. It was developed by German company Byk Gulden; 2-chloroform Base-3,4-dimethoxypyridine hydrochloride is one of the two intermediates in the synthesis of pandoprazole, 2-hydroxymethyl-3,4-dimethoxypyridine is the synthesis of 2-chloromethyl-3, An important intermediate of 4-dimethoxypyridine hydrochloride.
现有技术中潘多拉唑中间体2-氯甲基-3,4-二甲氧基吡啶盐酸盐的合成方法是以麦芽酚为起始原料,通过甲基化反应、氨化、氯化、氧化、甲醇钠甲氧化、乙酸酐异构化得到2-羟甲基-3,4-二甲氧基吡啶,再二次氯化成盐得到产品2-氯甲基-3,4-二甲氧基吡啶盐酸盐。可以看出2-羟甲基-3,4-二甲氧基吡啶是制备2-氯甲基-3,4-二甲氧基吡啶盐酸盐的关键中间体,其合成具有重要的价值。In the prior art, the synthetic method of Pandoprazole intermediate 2-chloromethyl-3,4-dimethoxypyridine hydrochloride is to take maltol as starting raw material, through methylation reaction, ammoniation, chlorination, Oxidation, sodium methoxide methoxide, acetic anhydride isomerization to obtain 2-hydroxymethyl-3,4-dimethoxypyridine, and then chlorination to salt to obtain the product 2-chloromethyl-3,4-dimethoxy Pyridine hydrochloride. It can be seen that 2-hydroxymethyl-3,4-dimethoxypyridine is a key intermediate for the preparation of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride, and its synthesis is of great value.
现有技术1(2-氯甲基-3,4-二甲氧基吡啶盐酸盐的制备,李荣东,徐燕,中国医药工业杂志,2000,31(10):475-476)具体公开了采用醋酐与3,4-二甲氧基-2-甲基吡啶-N-氧化物加热回流2h,减压除去醋酐,向剩余油状物中加入氢氧化钠溶液,在80℃下搅拌4h,冷却后,用二氯甲烷萃取,水洗至中性,无水硫酸钠干燥,蒸干二氯甲烷,得2-羟甲基-3,4-二甲氧基吡啶。Prior art 1 (preparation of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride, Li Rongdong, Xu Yan, Chinese Journal of Pharmaceutical Industry, 2000, 31(10): 475-476) specifically discloses Heat reflux with acetic anhydride and 3,4-dimethoxy-2-methylpyridine-N-oxide for 2 hours, remove the acetic anhydride under reduced pressure, add sodium hydroxide solution to the remaining oil, and stir at 80°C for 4 hours , after cooling, extracted with dichloromethane, washed with water until neutral, dried over anhydrous sodium sulfate, and evaporated to dry dichloromethane to obtain 2-hydroxymethyl-3,4-dimethoxypyridine.
现有技术2(2-氯甲基-3,4-二甲氧基吡啶盐酸盐的制备,刘德龙等,徐州师范大学学报(自然科学版),2003,21(1))具体公开了羟甲基化反应中将醋酐加热到85℃,逐渐加入3,4-二甲氧基-2-甲基吡啶-N-氧化物,然后在135℃下回流3h,减压除去醋酐,向残余油状物中加入氢氧化钠溶液,在80℃下搅拌3.5h,冷却后,反应液以二氯甲烷萃取,水洗至中性,加无水硫酸钠干燥,蒸去二氯甲烷,得2-羟甲基-3,4-二甲氧基吡啶。Prior art 2 (preparation of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride, Liu Delong et al., Journal of Xuzhou Normal University (Natural Science Edition), 2003, 21 (1)) specifically discloses the In the methylation reaction, heat acetic anhydride to 85°C, gradually add 3,4-dimethoxy-2-methylpyridine-N-oxide, then reflux at 135°C for 3 hours, remove acetic anhydride under reduced pressure, and Sodium hydroxide solution was added to the residual oil, and stirred at 80°C for 3.5 hours. After cooling, the reaction solution was extracted with dichloromethane, washed with water until neutral, dried with anhydrous sodium sulfate, and dichloromethane was distilled off to obtain 2- Hydroxymethyl-3,4-dimethoxypyridine.
现有技术3(申请号:201010136871.8,名称:潘托拉唑中间体吡啶盐酸盐的工业制备方法,公开日:2010.11.03)具体公开了:(1)制备3-甲氧基-2-甲基-4H-吡喃-4-酮;(2)制备3-甲氧基-2-甲基-4(IH)-吡啶酮;(3)制备4-氯-3-甲氧基-2-甲基吡啶;(4)制备4-氯-3-甲氧基-2-甲基吡啶-N-氧化物;(5)制备3,4-二甲氧基-2-甲基吡啶-N-氧化物;(6)制备2-羟甲基-3,4-二甲氧基吡啶;(7)制备2-氯甲基-3,4-二甲氧基吡啶盐酸盐。羟甲基化反应采用3,4-二甲氧基-2-甲基吡啶-N-氧化物中加入醋酐,然后升温到50-60℃保温16h,蒸去醋酐,向残留物中加入强碱调pH为9,在65-70℃下搅拌2h,冷却后,用有机溶剂萃取3-4次,蒸去有机溶剂,得棕黄色2-羟甲基-3,4-二甲氧基吡啶固体。Prior Art 3 (Application No.: 201010136871.8, Name: Industrial Preparation Method of Pantoprazole Intermediate Pyridine Hydrochloride, Publication Date: 2010.11.03) specifically discloses: (1) Preparation of 3-methoxy-2- Methyl-4H-pyran-4-one; (2) preparation of 3-methoxy-2-methyl-4(IH)-pyridinone; (3) preparation of 4-chloro-3-methoxy-2 -methylpyridine; (4) preparation of 4-chloro-3-methoxyl-2-methylpyridine-N-oxide; (5) preparation of 3,4-dimethoxyl-2-methylpyridine-N -oxide; (6) preparation of 2-hydroxymethyl-3,4-dimethoxypyridine; (7) preparation of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride. Add acetic anhydride to 3,4-dimethoxy-2-methylpyridine-N-oxide for hydroxymethylation reaction, then raise the temperature to 50-60°C for 16 hours, distill off the acetic anhydride, and add Adjust the pH to 9 with a strong base, stir at 65-70°C for 2 hours, after cooling, extract with organic solvent for 3-4 times, evaporate the organic solvent to obtain brown yellow 2-hydroxymethyl-3,4-dimethoxy Pyridine solid.
现有技术4(申请号:201110172014.8,名称:一种2-氯甲基-3,4-二甲氧基吡啶盐酸盐的制备方法,公开日:2012.01.04)具体公开了以麦芽酚为原料,依次经甲基化、氨化、氯代、氧化、甲氧基取代、羟甲基化和二次氯代反应生成得2-氯甲基-3,4-二甲氧基吡啶盐酸盐。羟甲基化反应中将醋酐加热到80-90℃,逐渐加入3,4-二甲氧基-2-甲基吡啶-N-氧化物,然后在120-140℃下回流2-4h,减压除去醋酐,向剩余油状物中加入氢氧化钠溶液,在80-90℃下搅拌3-4h,冷却后,反应液以二氯甲烷萃取三次,水洗至中性,加无水硫酸钠干燥,蒸去二氯甲烷,冷却析晶,得2-羟甲基-3,4-二甲氧基吡啶。Prior art 4 (application number: 201110172014.8, name: a preparation method of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride, publication date: 2012.01.04) specifically discloses that maltol is used as Raw materials, sequentially undergo methylation, ammoniation, chlorination, oxidation, methoxy substitution, hydroxymethylation and secondary chlorination to generate 2-chloromethyl-3,4-dimethoxypyridine hydrochloride Salt. In the methylolation reaction, heat acetic anhydride to 80-90°C, gradually add 3,4-dimethoxy-2-methylpyridine-N-oxide, and then reflux at 120-140°C for 2-4h, Remove acetic anhydride under reduced pressure, add sodium hydroxide solution to the remaining oil, stir at 80-90°C for 3-4h, after cooling, extract the reaction solution three times with dichloromethane, wash with water until neutral, add anhydrous sodium sulfate Dry, evaporate dichloromethane, cool and crystallize to obtain 2-hydroxymethyl-3,4-dimethoxypyridine.
综上所述,制备2-羟甲基-3,4-二甲氧基吡啶的方法中,均以3,4-二甲氧基-2-甲基吡啶-N-氧化物为原料,采用大大过量的乙酸酐作反应物又作反应溶剂,由于在制备过程中乙酸酐过量,增加企业成本,生产工艺反应温度较高,安全系数降低,而且反应收率低,导致合成潘多拉唑中间体—2-氯甲基-3,4-二甲氧基吡啶盐酸盐的总收率降低,从而影响潘多拉唑的工业化生产。In summary, in the method for preparing 2-hydroxymethyl-3,4-dimethoxypyridine, all use 3,4-dimethoxy-2-methylpyridine-N-oxide as raw material, adopt A large excess of acetic anhydride is used as a reactant and as a reaction solvent. Due to the excessive amount of acetic anhydride in the preparation process, the cost of the enterprise is increased, the reaction temperature of the production process is high, the safety factor is reduced, and the reaction yield is low, resulting in the synthesis of Pandoprazole intermediate— The overall yield of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride decreased, thereby affecting the industrial production of pandoprazole.
现有技术5(申请号:201410823414.4,名称:一种泮托拉唑中间体2-氯甲基-3,4-二甲氧基吡啶盐酸盐的制备方法,公开日:2015.04.29)具体公开了一种泮托拉唑中间体2-氯甲基-3,4-二甲氧基吡啶盐酸盐的制备方法:以3-羟基-2-甲基-4-吡喃酮为起始原料,经氨化、甲氧基化、氧化、羟甲基化和氯代五步反应制备2-氯甲基-3,4-二甲氧基吡啶盐酸盐,在羟甲基化反应中用3,4-二甲氧基-2-甲基吡啶N-氧化物与乙酸酐在高温回流4h,然后减压除去乙酸酐,向油状物中加水,用碱液调节pH值8-9,后加入NaOH固体,在80℃下搅拌4h,冷却,二氯甲烷萃取,水洗至中性,加无水硫酸钠干燥,蒸去二氯甲烷,得白色晶体2-羟甲基-3,4-二甲氧基吡啶,见图1。虽然该反应收率达到90%,但是反应温度较高,反应过程中加固体碱,难以控制,安全性低,且反应采用过量的乙酸酐即作溶剂又作反应物,增加企业成本。Prior art 5 (application number: 201410823414.4, name: a preparation method of pantoprazole intermediate 2-chloromethyl-3,4-dimethoxypyridine hydrochloride, publication date: 2015.04.29) specific Disclosed is a preparation method of pantoprazole intermediate 2-chloromethyl-3,4-dimethoxypyridine hydrochloride: starting with 3-hydroxy-2-methyl-4-pyrone Raw materials, 2-chloromethyl-3,4-dimethoxypyridine hydrochloride prepared by five-step reaction of ammoniation, methoxylation, oxidation, hydroxymethylation and chlorination, in the hydroxymethylation reaction Use 3,4-dimethoxy-2-methylpyridine N-oxide and acetic anhydride to reflux at high temperature for 4 hours, then remove acetic anhydride under reduced pressure, add water to the oil, and adjust the pH value to 8-9 with lye, Then add solid NaOH, stir at 80°C for 4h, cool, extract with dichloromethane, wash with water until neutral, add anhydrous sodium sulfate to dry, evaporate dichloromethane to obtain white crystal 2-hydroxymethyl-3,4- Dimethoxypyridine, see Figure 1. Although the reaction yield reaches 90%, the reaction temperature is high, solid alkali is added in the reaction process, it is difficult to control, and the safety is low, and the reaction uses excessive acetic anhydride as solvent and reactant, which increases the cost of the enterprise.
因此,亟需一种收率高、安全性可靠的2-羟甲基-3,4-二甲氧基吡啶的制备方法。Therefore, there is an urgent need for a high-yield, safe and reliable preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine.
发明内容Contents of the invention
为解决上述问题,本发明提供一种2-羟甲基-3,4-二甲氧基吡啶的制备方法,收率高,反应条件温和,安全可靠,降低乙酸酐用量,降低成本,解决了现有技术存在的问题。In order to solve the above problems, the present invention provides a preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine, which has high yield, mild reaction conditions, safety and reliability, reduces the amount of acetic anhydride, reduces costs, and solves the problem of Problems existing in the prior art.
本发明所采用的技术方案是,一种2-羟甲基-3,4-二甲氧基吡啶的制备方法,具体按照以下步骤进行:The technical scheme adopted in the present invention is a preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine, which is specifically carried out according to the following steps:
步骤1,按比例,将20~30kg 3,4-二甲氧基-2-甲基吡啶-N-氧化物加入到10~20kg的乙酸中,机械搅拌下加热至75~85℃,完全溶解;Step 1, in proportion, add 20~30kg of 3,4-dimethoxy-2-methylpyridine-N-oxide into 10~20kg of acetic acid, heat to 75~85℃ under mechanical stirring, and dissolve completely ;
步骤2,称取50~75kg的乙酸酐,80~85℃时,在搅拌下缓慢加入步骤1的体系中,乙酸酐的滴加速率为10~15kg/h;然后在85~95℃下保温15~16h,得到反应液;Step 2, weigh 50-75kg of acetic anhydride, and slowly add it into the system of step 1 under stirring at 80-85°C, the dripping rate of acetic anhydride is 10-15kg/h; then keep it warm at 85-95°C 15 to 16 hours to obtain the reaction solution;
步骤3,将反应液在85~90℃、0.092MPa下减压蒸馏出80~90%乙酸酐后,降至18~25℃,缓慢加碱调pH至12~13,升温45~55℃搅拌水解2h,水解完全后降至18~25℃;Step 3: Distill the reaction solution under reduced pressure at 85-90°C and 0.092MPa to distill 80-90% acetic anhydride, then lower it to 18-25°C, slowly add alkali to adjust the pH to 12-13, heat up to 45-55°C and stir Hydrolyze for 2 hours, and drop to 18-25°C after complete hydrolysis;
步骤4,向体系中加二氯甲烷0.8~1.2kg,搅拌1h,静置分液,再用等量二氯甲烷分别萃取2次,向合并的萃取液中加无水硫酸钠0.5~0.8kg,搅拌干燥,旋蒸,回收二氯甲烷,即得。Step 4: Add 0.8-1.2 kg of dichloromethane to the system, stir for 1 hour, let stand to separate the liquids, then extract twice with an equal amount of dichloromethane, and add 0.5-0.8 kg of anhydrous sodium sulfate to the combined extract , stirring and drying, rotary evaporation, recovery of dichloromethane, that is.
本发明的特征还在于,进一步的,所述步骤3中,碱为质量浓度20%的NaOH溶液。The present invention is also characterized in that, further, in the step 3, the alkali is NaOH solution with a mass concentration of 20%.
本发明的有益效果是,本发明先用乙酸溶解3,4-二甲氧基-2-甲基吡啶-N-氧化物,使3,4-二甲氧基-2-甲基吡啶-N-氧化物以分子状态分散在反应体系,在提高反应速率的同时,目的产物收率提高15~20%;用乙酸溶解3,4-二甲氧基-2-甲基吡啶-N-氧化物,使3,4-二甲氧基-2-甲基吡啶-N-氧化物以分子状态分散在反应体系,在此条件下酰化反应能力增强,能够充分发挥乙酸酐的酰化作用,提高了收率的同时减少乙酸酐用量,节省成本。The beneficial effects of the present invention are that the present invention first dissolves 3,4-dimethoxy-2-picoline-N-oxide with acetic acid to make 3,4-dimethoxy-2-picoline-N -Oxide is dispersed in the reaction system in a molecular state, while increasing the reaction rate, the yield of the target product is increased by 15-20%; dissolve 3,4-dimethoxy-2-methylpyridine-N-oxide with acetic acid , so that 3,4-dimethoxy-2-picoline-N-oxide is dispersed in the reaction system in a molecular state. While improving the yield, the consumption of acetic anhydride is reduced, and the cost is saved.
本发明乙酸酐的滴加速率为50~65kg/小时,在该时间段能够充分发挥酰化作用,增加酰化产物(C)重排生成2-羟甲基-3,4-二甲氧基吡啶前驱体3,4-二甲氧基-2-乙酸甲酯吡啶(D)量,减少副产物3,4-二甲氧基-2-甲基-5-乙酸甲酯吡啶(E)的生成,提高转化率。The dropping rate of acetic anhydride in the present invention is 50-65kg/hour, and the acylation effect can be fully exerted in this time period, and the rearrangement of the acylated product (C) can be increased to generate 2-hydroxymethyl-3,4-dimethoxy The amount of pyridine precursor 3,4-dimethoxy-2-methylpyridine acetate (D) reduces the amount of by-product 3,4-dimethoxy-2-methyl-5-methylpyridine acetate (E) Generate, increase conversion rate.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. Those skilled in the art can also obtain other drawings based on these drawings without creative work.
图1是2-羟甲基-3,4-二甲氧基吡啶的现有制备方法流程图。Fig. 1 is a flow chart of the existing preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine.
图2是本发明实施例的制备流程图。Fig. 2 is the preparation flowchart of the embodiment of the present invention.
图3是本发明实施例2制得的2-羟甲基-3,4-二甲氧基吡啶的高效液相色谱图。Fig. 3 is a high performance liquid chromatogram of 2-hydroxymethyl-3,4-dimethoxypyridine prepared in Example 2 of the present invention.
具体实施方式Detailed ways
以下结合附图和具体实施例,对本发明作进一步详细阐述。应当理解,所述实施例仅用于说明本发明,而不用于限制本发明的保护范围。此外应理解,在阅读了本发明描述的内容以后,本领域技术人员可以对本发明做各种改动或修改,这些等价形式同样落于本申请所限定的保护范围。The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be understood that the examples are only used to illustrate the present invention, but not to limit the protection scope of the present invention. In addition, it should be understood that after reading the content of the present invention, those skilled in the art may make various changes or modifications to the present invention, and these equivalent forms also fall within the scope of protection defined in the present application.
实施例1,Example 1,
2-羟甲基-3,4-二甲氧基吡啶的制备方法,见图2,具体按照以下步骤进行:The preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine is shown in Figure 2, and specifically carried out according to the following steps:
步骤1,将20kg 3,4-二甲氧基-2-甲基吡啶-N-氧化物加入到20kg的乙酸中,机械搅拌下加热至75℃,完全溶解;Step 1, add 20kg of 3,4-dimethoxy-2-methylpyridine-N-oxide into 20kg of acetic acid, heat to 75°C under mechanical stirring, and dissolve completely;
步骤2,称取50kg的乙酸酐,80℃时,在搅拌下缓慢加入步骤1的体系中,乙酸酐的滴加速率为15kg/h;然后在85℃下保温16h,得到反应液;Step 2: Weigh 50kg of acetic anhydride, and slowly add it to the system of step 1 under stirring at 80°C, the dropping rate of acetic anhydride is 15kg/h; then keep warm at 85°C for 16h to obtain a reaction solution;
步骤3,将反应液在85℃、0.092MPa下减压蒸馏出90%乙酸酐后,降至室温(18~25℃),缓慢加碱调pH至12~13,碱为质量浓度20%的NaOH,升温55℃搅拌水解2h,水解完全后降至室温(18~25℃);Step 3: Distill the reaction solution under reduced pressure at 85°C and 0.092MPa to remove 90% acetic anhydride, then lower it to room temperature (18-25°C), slowly add alkali to adjust the pH to 12-13, the alkali is 20% mass concentration NaOH, heat up to 55°C and stir to hydrolyze for 2 hours, then cool down to room temperature (18-25°C) after complete hydrolysis;
步骤4,向体系中加1.2kg二氯甲烷,搅拌1h,静置分液,再用二氯甲烷萃取2次,向合并的萃取液中加无水硫酸钠0.8kg搅拌干燥,旋蒸,回收二氯甲烷;得红棕色晶体,即2-羟甲基-3,4-二甲氧基吡啶。Step 4, add 1.2kg of dichloromethane to the system, stir for 1h, let stand to separate the liquid, then extract twice with dichloromethane, add 0.8kg of anhydrous sodium sulfate to the combined extract, stir and dry, rotary evaporate, and recover Dichloromethane; in reddish-brown crystals, namely 2-hydroxymethyl-3,4-dimethoxypyridine.
实施例2,Example 2,
2-羟甲基-3,4-二甲氧基吡啶的制备方法,具体按照以下步骤进行:The preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine is specifically carried out according to the following steps:
步骤1,将25kg 3,4-二甲氧基-2-甲基吡啶-N-氧化物加人到12.5kg的乙酸中,机械搅拌下加热到80℃,完全溶解;Step 1, add 25kg of 3,4-dimethoxy-2-picoline-N-oxide into 12.5kg of acetic acid, heat to 80°C under mechanical stirring, and dissolve completely;
步骤2,称取70kg乙酸酐,83℃时,在搅拌下缓慢加入步骤1的体系中,乙酸酐的滴加速率为14.8kg/小时,5h加完,88℃下保温反应14h,得到反应液;Step 2: Weigh 70kg of acetic anhydride, and at 83°C, slowly add it into the system of step 1 under stirring. The drop rate of acetic anhydride is 14.8kg/hour, add it in 5h, keep it warm at 88°C for 14h, and obtain the reaction solution ;
步骤3,将反应液在85℃、0.092MPa下减压蒸馏出85%乙酸酐后,降至室温(18~25℃),缓慢加碱调pH至12~13,碱为质量浓度20%的NaOH溶液,升温至50℃搅拌水解2h,水解完全后降至室温(18~25℃);Step 3: Distill the reaction solution under reduced pressure at 85°C and 0.092MPa to distill 85% acetic anhydride, then lower it to room temperature (18-25°C), slowly add alkali to adjust the pH to 12-13, the alkali is 20% mass concentration NaOH solution, heated up to 50°C, stirred and hydrolyzed for 2 hours, and cooled to room temperature (18-25°C) after complete hydrolysis;
步骤4,向体系中加1kg二氯甲烷,搅拌1h,静置分液,再用二氯甲烷萃取2次,向合并的萃取液中加无水硫酸钠0.7kg搅拌干燥,旋蒸,回收二氯甲烷,得红棕色晶体,即2-羟甲基-3,4-二甲氧基吡啶。Step 4, add 1 kg of dichloromethane to the system, stir for 1 h, let stand to separate the liquid, then extract 2 times with dichloromethane, add 0.7 kg of anhydrous sodium sulfate to the combined extract, stir and dry, rotary evaporate, and recover two Chloromethane, in reddish-brown crystals, that is, 2-hydroxymethyl-3,4-dimethoxypyridine.
实施例3,Example 3,
2-羟甲基-3,4-二甲氧基吡啶的制备方法,具体按照以下步骤进行:The preparation method of 2-hydroxymethyl-3,4-dimethoxypyridine is specifically carried out according to the following steps:
步骤1,将30kg3,4-二甲氧基-2-甲基吡啶-N-氧化物加入到10kg的乙酸中,机械搅拌下加热至85℃,完全溶解;Step 1, add 30kg of 3,4-dimethoxy-2-methylpyridine-N-oxide into 10kg of acetic acid, heat to 85°C under mechanical stirring, and dissolve completely;
步骤2,称取75kg的乙酸酐,85℃时,在搅拌下缓慢加入步骤1的体系中,乙酸酐的滴加速率为10kg/h;然后在95℃下保温15h,得到反应液;Step 2, weighing 75kg of acetic anhydride, at 85°C, slowly adding to the system of step 1 under stirring, the dripping rate of acetic anhydride is 10kg/h;
步骤3,将反应液在90℃、0.092MPa下减压蒸馏出80%乙酸酐后,降至室温(18~25℃),缓慢加碱调pH至12~13,碱为质量浓度20%的NaOH,升温45℃搅拌水解2h,水解完全后降至室温(18~25℃);Step 3: Distill the reaction solution under reduced pressure at 90°C and 0.092MPa to distill 80% acetic anhydride, then lower it to room temperature (18-25°C), slowly add alkali to adjust the pH to 12-13, and the alkali is 20% mass concentration NaOH, heat up to 45°C and stir for 2 hours to hydrolyze, then cool down to room temperature (18-25°C) after complete hydrolysis;
步骤4,向体系中加0.8kg二氯甲烷,搅拌1h,静置分液,再用二氯甲烷萃取2次,向合并的萃取液中加无水硫酸钠0.5kg搅拌干燥,旋蒸,回收二氯甲烷;得红棕色晶体,即2-羟甲基-3,4-二甲氧基吡啶。Step 4, add 0.8 kg of dichloromethane to the system, stir for 1 h, let stand to separate the liquid, then extract twice with dichloromethane, add 0.5 kg of anhydrous sodium sulfate to the combined extract, stir and dry, rotary evaporate, and recover Dichloromethane; in reddish-brown crystals, namely 2-hydroxymethyl-3,4-dimethoxypyridine.
生成2-羟甲基-3,4-二甲氧基吡啶前驱体3,4-二甲氧基-2-乙酸甲酯吡啶(D)的反应原理:The reaction principle of generating 2-hydroxymethyl-3,4-dimethoxypyridine precursor 3,4-dimethoxy-2-acetate methyl pyridine (D):
本发明先用乙酸溶解3,4-二甲氧基-2-甲基吡啶-N-氧化物,使3,4-二甲氧基-2-甲基吡啶-N-氧化物以分子状态分散在反应体系,在提高反应速率的同时,目的产物收率提高15~20%。The present invention first dissolves 3,4-dimethoxy-2-picoline-N-oxide with acetic acid, so that 3,4-dimethoxy-2-picoline-N-oxide is dispersed in molecular state In the reaction system, while increasing the reaction rate, the yield of the target product is increased by 15-20%.
乙酸(HAc)与上工段残留在B5(2-甲基-3-甲氧基-4-氯吡啶-N-氧化物)原料中的NaOH反应生成乙酰基CH3CO-(或记为Ac-),而乙酰基CH3CO-对其与3,4-二甲氧基-2-甲基吡啶-N-氧化物(A)作用生成3,4-二甲氧基-2-甲基-乙酰吡啶-N-氧化物(B)、及进一步与(B)酰化生成(C)的反应有促进作用;乙酸(HAc)有利于酰化产物(C)重排生成2-羟甲基-3,4-二甲氧基吡啶前驱体3,4-二甲氧基-2-乙酸甲酯吡啶(D)的同时,还能抑制副产物3,4-二甲氧基-2-甲基-5-乙酸甲酯吡啶(E)的生成。Acetic acid (HAc) reacts with the NaOH remaining in the B5 (2-methyl-3-methoxy-4-chloropyridine-N-oxide) raw material in the previous process to generate acetyl CH 3 CO - (or denoted as Ac - ), and acetyl CH 3 CO - reacts with 3,4-dimethoxy-2-methylpyridine-N-oxide (A) to generate 3,4-dimethoxy-2-methyl- Acetylpyridine-N-oxide (B), and the further reaction with (B) acylation to generate (C) has a promoting effect; acetic acid (HAc) is conducive to the rearrangement of acylated product (C) to generate 2-hydroxymethyl- 3,4-dimethoxypyridine precursor 3,4-dimethoxy-2-acetate methylpyridine (D), can also inhibit the by-product 3,4-dimethoxy-2-methyl - Formation of 5-methylpyridine acetate (E).
乙酸酐滴加过快或直接加到反应体系中,酰化速率小于分解速率,不利于酯化反应的进行;本发明限定了乙酸酐的滴加速率为50~65kg/小时,在该时间段能够充分发挥酰化作用,增加酰化产物(C)重排生成2-羟甲基-3,4-二甲氧基吡啶前驱体3,4-二甲氧基-2-乙酸甲酯吡啶(D)量,减少副产物3,4-二甲氧基-2-甲基-5-乙酸甲酯吡啶(E)的生成,提高转化率。If acetic anhydride is added dropwise too quickly or directly into the reaction system, the acylation rate is less than the decomposition rate, which is unfavorable for the carrying out of the esterification reaction; Can give full play to the acylation effect, increase the rearrangement of the acylated product (C) to generate 2-hydroxymethyl-3,4-dimethoxypyridine precursor 3,4-dimethoxy-2-acetate methyl pyridine ( D) amount, reduce the generation of by-product 3,4-dimethoxy-2-methyl-5-methylpyridine acetate (E), and improve the conversion rate.
根据反应原理,乙酸酐与3,4-二甲氧基-2-甲基吡啶-N-氧化物的用量比应该是1:1,本发明乙酸酐与3,4-二甲氧基-2-甲基吡啶-N-氧化物的质量比为2~3:1,比现有技术的比例5~8:1明显降低,用乙酸溶解3,4-二甲氧基-2-甲基吡啶-N-氧化物,使3,4-二甲氧基-2-甲基吡啶-N-氧化物以分子状态分散在反应体系,在此条件下酰化反应能力增强,能够充分发挥乙酸酐的酰化作用,提高了收率的同时减少乙酸酐用量,节省成本。According to the reaction principle, the consumption ratio of acetic anhydride and 3,4-dimethoxy-2-methylpyridine-N-oxide compound should be 1:1, and acetic anhydride of the present invention and 3,4-dimethoxy-2 -The mass ratio of picoline-N-oxide is 2 to 3:1, which is significantly lower than the ratio of 5 to 8:1 in the prior art, and 3,4-dimethoxy-2-picoline is dissolved with acetic acid -N-oxide, so that 3,4-dimethoxy-2-methylpyridine-N-oxide is dispersed in the reaction system in a molecular state. Under this condition, the acylation reaction ability is enhanced, and the acetic anhydride can be fully utilized Acylation improves the yield while reducing the consumption of acetic anhydride and saving costs.
本发明步骤3中,将反应液减压蒸馏出乙酸酐后,降至室温(18~25℃),缓慢加碱调pH至12~13,升温搅拌水解2h至水解完全后降至室温;先蒸馏出乙酸酐,回收继续利用,降低乙酸酐用量,降低成本。降至室温后再加碱是因为会有残留的乙酸酐,因为碱液中的水与未反应的乙酸酐会发生水解反应,生成乙酸,乙酸与氢氧化钠反应是一个剧烈且放热的反应,如果不降温或者碱液浓度过高,容易出现安全事故,碱液浓度过低不能增加碱液用量,对后续处理带来困难,因此碱采用质量浓度20%的NaOH溶液。本发明反应过程中会生成中间产物C,C在碱性条件和温度50℃下搅拌水解得到产物2-羟甲基-3,4-二甲氧基吡啶,如果pH过高或者过低都不能很好的水解成产物,降低产物的产率,因此调节pH至12~13。In step 3 of the present invention, after distilling the acetic anhydride out of the reaction solution under reduced pressure, lower it to room temperature (18-25° C.), slowly add alkali to adjust the pH to 12-13, heat up and stir for 2 hours to hydrolyze and then lower it to room temperature; Acetic anhydride is distilled and recycled for continued use, reducing the consumption of acetic anhydride and reducing costs. Add alkali after cooling down to room temperature because there will be residual acetic anhydride, because the water in the lye will hydrolyze with unreacted acetic anhydride to generate acetic acid, and the reaction between acetic acid and sodium hydroxide is a violent and exothermic reaction If the temperature is not lowered or the concentration of lye is too high, safety accidents will easily occur. If the concentration of lye is too low, the amount of lye cannot be increased, which will bring difficulties to subsequent processing. Therefore, the alkali adopts a NaOH solution with a mass concentration of 20%. In the reaction process of the present invention, an intermediate product C will be generated, and C will be hydrolyzed under alkaline conditions and a temperature of 50° C. to obtain the product 2-hydroxymethyl-3,4-dimethoxypyridine. If the pH is too high or too low, it cannot Very good hydrolysis into products reduces the yield of products, so adjust the pH to 12-13.
实施例2制得的2-羟甲基-3,4-二甲氧基吡啶,称重计算收率为95.6%,纯度见高效液相色谱图,纯度为94.95%,见图3,高效液相色谱图的各峰对应参数见表1。The 2-hydroxymethyl-3,4-dimethoxypyridine prepared in Example 2 has a yield of 95.6% by weight, and the purity is shown in the high-performance liquid chromatogram, and the purity is 94.95%, as shown in Figure 3. The corresponding parameters of each peak in the phase chromatogram are shown in Table 1.
表1 本发明制得的2-羟甲基-3,4-二甲氧基吡啶的高效液相色谱图的各峰对应参数Table 1 The parameters corresponding to the peaks of the high performance liquid chromatography of 2-hydroxymethyl-3,4-dimethoxypyridine prepared by the present invention
根据图3、表1可知,实施例2制得的2-羟甲基-3,4-二甲氧基吡啶纯度较高,符合生产使用要求;2-氯甲基-3,4-二甲氧基吡啶盐酸盐是合成种潘多拉唑两个中间体之一,2-羟甲基-3,4-二甲氧基吡啶是合成2-氯甲基-3,4-二甲氧基吡啶盐酸盐的重要中间体;2-羟甲基-3,4-二甲氧基吡啶纯度较高,进而提高合成的2-氯甲基-3,4-二甲氧基吡啶盐酸盐的纯度和产率,进一步的讲,最终影响潘多拉唑的纯度和收率。According to Figure 3 and Table 1, it can be seen that the 2-hydroxymethyl-3,4-dimethoxypyridine prepared in Example 2 has a higher purity and meets the requirements for production and use; 2-chloromethyl-3,4-dimethyl Oxypyridine hydrochloride is one of the two intermediates in the synthesis of Pandoprazole, and 2-hydroxymethyl-3,4-dimethoxypyridine is the synthesis of 2-chloromethyl-3,4-dimethoxypyridine An important intermediate of hydrochloride; the purity of 2-hydroxymethyl-3,4-dimethoxypyridine is relatively high, thereby improving the synthesis of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride Purity and productive rate, further speaking, finally influence the purity and the yield of pandoprazole.
对比例,comparative example,
将25kg 3,4-二甲氧基-2-甲基吡啶-N-氧化物加入到反应釜中,然后加入70kg乙酸酐,机械搅拌下使完全溶解;然后缓慢升温至88℃回流保温6-9h,得到反应液;将反应液在85℃、0.092MPa下减压蒸馏出85%乙酸酐后,降至室温(18~25℃),加入90kg水搅拌,缓慢加质量浓度20%的NaOH调pH至12~13,然后升温50℃搅拌水解2h,水解完全后降至室温(18~25℃);向体系中加1kg二氯甲烷,搅拌1h,静置分液,再用二氯甲烷萃取2次,向合并的萃取液中加无水硫酸钠0.7kg搅拌干燥,旋蒸,回收二氯甲烷;得红棕色晶体,即2-羟甲基-3,4-二甲氧基吡啶。称重计算收率为75.8%,明显小于实施例2的收率。Add 25kg of 3,4-dimethoxy-2-methylpyridine-N-oxide into the reaction kettle, then add 70kg of acetic anhydride, and dissolve it completely under mechanical stirring; then slowly raise the temperature to 88°C for 6- After 9h, the reaction solution was obtained; after the reaction solution was distilled off 85% acetic anhydride under reduced pressure at 85°C and 0.092MPa, it was lowered to room temperature (18-25°C), stirred with 90kg of water, and slowly added NaOH with a mass concentration of 20%. pH to 12-13, then heat up to 50°C and stir for 2 hours to hydrolyze, then drop to room temperature (18-25°C) after complete hydrolysis; add 1 kg of dichloromethane to the system, stir for 1 hour, let stand to separate liquids, and then extract with dichloromethane Twice, add 0.7 kg of anhydrous sodium sulfate to the combined extracts, stir and dry, rotary evaporate, and recover dichloromethane; obtain reddish-brown crystals, namely 2-hydroxymethyl-3,4-dimethoxypyridine. The calculated yield by weighing is 75.8%, obviously less than the yield of Example 2.
以上所述仅为本发明的较佳实施例而已,并非用于限定本发明的保护范围。凡在本发明的精神和原则之内所作的任何修改、等同替换、改进等,均包含在本发明的保护范围内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principles of the present invention are included in the protection scope of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810014813.4A CN108191745A (en) | 2018-01-08 | 2018-01-08 | The preparation method of 2- methylol -3,4- dimethoxy-pyridines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810014813.4A CN108191745A (en) | 2018-01-08 | 2018-01-08 | The preparation method of 2- methylol -3,4- dimethoxy-pyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108191745A true CN108191745A (en) | 2018-06-22 |
Family
ID=62588160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810014813.4A Pending CN108191745A (en) | 2018-01-08 | 2018-01-08 | The preparation method of 2- methylol -3,4- dimethoxy-pyridines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108191745A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110746350A (en) * | 2019-09-30 | 2020-02-04 | 安徽金禾实业股份有限公司 | Anhydridization synthesis method in pyridine hydrochloride production |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1032340A (en) * | 1987-08-15 | 1989-04-12 | 赫彻斯特股份公司 | The Thienoimidazole derivatives that replaces, its preparation method and contain the pharmaceutical preparation of this derivative and they are as the purposes of gastric acid secretion inhibitor |
CN104557692A (en) * | 2014-12-26 | 2015-04-29 | 寿光富康制药有限公司 | Preparation method of pantoprazole intermediate 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride |
CN105153019A (en) * | 2015-08-10 | 2015-12-16 | 安徽国星生物化学有限公司 | 2-pyridinemethanol and synthetic method thereof |
CN106083705A (en) * | 2016-06-14 | 2016-11-09 | 上药康丽(常州)药业有限公司 | The preparation method of 2 methylol 4 (methoxy propoxy) 3 methyl pyridinium chloride |
-
2018
- 2018-01-08 CN CN201810014813.4A patent/CN108191745A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1032340A (en) * | 1987-08-15 | 1989-04-12 | 赫彻斯特股份公司 | The Thienoimidazole derivatives that replaces, its preparation method and contain the pharmaceutical preparation of this derivative and they are as the purposes of gastric acid secretion inhibitor |
CN104557692A (en) * | 2014-12-26 | 2015-04-29 | 寿光富康制药有限公司 | Preparation method of pantoprazole intermediate 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride |
CN105153019A (en) * | 2015-08-10 | 2015-12-16 | 安徽国星生物化学有限公司 | 2-pyridinemethanol and synthetic method thereof |
CN106083705A (en) * | 2016-06-14 | 2016-11-09 | 上药康丽(常州)药业有限公司 | The preparation method of 2 methylol 4 (methoxy propoxy) 3 methyl pyridinium chloride |
Non-Patent Citations (1)
Title |
---|
魏文德 主编: "《有机化工原料大全 第二卷》", 31 May 1989, 化学工业出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110746350A (en) * | 2019-09-30 | 2020-02-04 | 安徽金禾实业股份有限公司 | Anhydridization synthesis method in pyridine hydrochloride production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106167449B (en) | A kind of synthetic method of parahydroxyacet-ophenone | |
CN101367760B (en) | The synthetic method of 2-chloronicotinic acid | |
CN104119367A (en) | Preparation method of aryl boric acid | |
CN105367526B (en) | A kind of preparation method of high-purity n butylphthalide | |
CN101891649A (en) | Novel 3-cyano methyl benzoate preparing method | |
CN108191745A (en) | The preparation method of 2- methylol -3,4- dimethoxy-pyridines | |
CN103508934A (en) | Preparation method of gliclazide | |
CN105348249B (en) | A kind of synthetic method of the ketone of 4 chloromethyl, 5 methyl, 1,3 dioxole 2 | |
CN102898328B (en) | Synthesis method of diethyl azodicarboxylate and intermediate of diethyl azodicarboxylate | |
CN106187715B (en) | A kind of synthetic method of 4- butoxy phenol | |
CN107973747A (en) | The preparation method of 2- methyl -3- methoxyl group -4- chloropyridines | |
CN107129466B (en) | Synthetic method of 4-chloro-3-methoxy-2-methylpyridine-N-oxide | |
CN104402711A (en) | Synthesis technology of intermediate of anti-asthma drug namely pranlukast | |
CN108218769A (en) | A kind of preparation method of sulfasalazine | |
CN102010325A (en) | Method for synthesizing p-hydroxyphenylacetic acid | |
CN103351311B (en) | A kind of synthetic method of diphenatril | |
CN105732375B (en) | A kind of method that gallic acid synthesizes 3,4,5-tri-methoxybenzoate | |
CN101381297A (en) | A method for separating octanoic acid from octadecanoic acid mixture | |
CN100509729C (en) | Method for synthesizing resveratrol | |
CN112159347B (en) | The preparation method of picotamide | |
CN113603663B (en) | Method for preparing biphenyl dianhydride isomer by ultrasonic-assisted catalytic coupling | |
CN109020810A (en) | A kind of method of continuous synthesizing methyl diethyl malonate | |
CN108675918A (en) | A kind of synthetic method of piceatannol | |
CN100588643C (en) | A kind of preparation method of retinoic acid compound containing disubstituted adamantyl group | |
CN108947793A (en) | A kind of preparation method of chlorine phenoxy carboxylic acid herbicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |
|
RJ01 | Rejection of invention patent application after publication |